Darya Bubman, PhD
Assistant Director
Innovation Ventures
Chancellor/EVC/FAS

Darya joined the Office of Innovation, Technology and Alliances (ITA) in November 2011. Her responsibilities include technology management, licensing and outgoing material transfer agreements. Darya earned a B.A. degree in Biochemistry from Cornell University in Ithaca, N.Y. and a Ph.D. in Pharmacology from the Weill Cornell Graduate School of Medical Sciences in New York City.

Show full bio (120 words) Hide full bio

She conducted her doctoral work in the laboratory of Dr. Ethel Cesarman, studying deregulation of cancer signaling pathways by the Kaposi’s sarcoma-associated herpesvirus (KSHV) in primary effusion lymphoma. Following her graduate studies, Darya became an AAAS Science and Technology Policy Fellow and worked at the U.S. State Department in the Intellectual Property Office on international issues related to biomedical IP, innovation, and technology transfer. Prior to joining the ITA, she worked as a Technology Partnerships Manager at the NASA Ames Research Center located at Moffett Field, CA. Darya has a strong background in virology, oncology, pharmacology and molecular biology.

Darya is passionate about working with UCSF faculty and staff to transfer novel UCSF biomedical technologies from bench to bedside.

Websites

Show all (1) Hide

• Office of Innovation, Technology & Alliances (ita.ucsf.edu)

Publications (6)

Top publication keywords:
Proto-Oncogene Proteins c-mycGene Expression Regulation, LeukemicCell Transformation, ViralNuclear ProteinsSarcoma, KaposiHerpesvirus 8, HumanViral Matrix ProteinsLymphoma, Non-HodgkinThreonineLymphoma, FollicularTNF Receptor-Associated Factor 2Herpesvirus 4, HumanAlcohol OxidoreductasesAntigens, ViralGlycogen Synthase Kinase 3 beta

• Expression of the follicular lymphoma variant translocation 1 gene in diffuse large B-cell lymphoma correlates with subtype and clinical outcome.
  American journal of clinical pathology 2008 Czuchlewski DR, Csernus B, Bubman D, Hyjek E, Martin P, Chadburn A, Knowles DM, Cesarman E
• EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.
  Blood 2008 Guasparri I, Bubman D, Cesarman E
• Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
  Oncogene 2007 Bubman D, Guasparri I, Cesarman E
• Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association.
  Journal of virology 2005 Fan W, Bubman D, Chadburn A, Harrington WJ, Cesarman E, Knowles DM
• Pathogenesis of Kaposi's sarcoma.
  Hematology/oncology clinics of North America 2003 Bubman D, Cesarman E
• Role of a novel soluble nucleotide phospho-hydrolase from sheep plasma in inhibition of platelet reactivity: hemostasis, thrombosis, and vascular biology.
  The Journal of laboratory and clinical medicine 2002 Birk AV, Bubman D, Broekman MJ, Robertson HD, Drosopoulos JH, Marcus AJ, Szeto HH